charminglane
Sea Witch
- Joined
- May 5, 2009
- Messages
- 8,092
- Reaction score
- 34,803
I had a Moderna yesterday.
Laid low today. Headache, nausea, body ache.
Laid low today. Headache, nausea, body ache.
All my early shots were Moderna, with normal unpleasant side effects for a few days. Then one time I got Pfizer, and I had zero side effects and barely even a sore arm. On the hopeful assumption that all the vaxxes are equal in effectiveness, I now favor Pfizer when given the option.Pfizer--that's all the pharmacy had. Most of our Covid shots have been Pfizer.
When the vax first came out Moderna had a stronger dose- I got Moderna at that time--- never had a bad reaction. I haven't had a vax in two years- for some reason I am hesitant with the new formulated vaccines. I was very hesitant to get vaxxed initially, but that was in 2021 when the pandemic was in full throttle and I put my fears aside. I then got a couple of boosters. I have never had a flu vaccine.All my early shots were Moderna, with normal unpleasant side effects for a few days. Then one time I got Pfizer, and I had zero side effects and barely even a sore arm. On the hopeful assumption that all the vaxxes are equal in effectiveness, I now favor Pfizer when given the option.
Novavax wasn't an option in my area early on, but now I think it might be? Is that one supposed to be better? Seems I've heard that.
I second that. I am thankful this thread got me through a rough time and calmed my fears.So grateful to have had this community during that crazy time.
Well, I didn't get my wish. Looks like they are going ahead with an update vaccine for JN.1 lineage, when KP.2 is dominant. I really need to give them my direct line so they can contact me about these sorts of things.Interesting... when I saw your post a while back I thought it had already been decided that this fall's formula would target JN.1, which I wasn't happy about that since KP.2 is growing faster and JN.1 was receding.
Original post with that chart HERE, and a snippet from it here: the trend is definitely showing that JN.1 (purple) is losing ground to KP.2 (gray). Also, it appears that KP.2 is growing at a faster pace (doubling) than JN.1 is declining (baby steps).
But now it appears a decision hasn't been made. The meeting was supposed to be today but it got pushed out until 6/5.
The May 16, 2024, VRBPAC Meeting has been rescheduled for June 5, 2024. This new date will allow for additional time to obtain surveillance data and other information so the VRBPAC Committee will have more up-to-date information when discussing and making recommendations. FDA does not anticipate that the date change will impact COVID-19 vaccine availability for the Fall.
VRBPAC May 16, 2024 Meeting Announcement
This is the main page for the Vaccines and Related Biological Products Advisory Committee (VRBPAC) May 16, 2024 Meeting announcement and meeting materials.www.fda.gov
So it looks like the formula is still up in the air:
We expect the next updated version of the COVID-19 vaccine to be released this fall, and the U.S. Food and Drug Administration’s (FDA) advisory committee is meeting June 5 to discuss and make recommendations on its formulation.
I get the weekly reports from the Boston Globe on Covid-19 cases in Massachusetts, and for the week of May 12-May 18 there were 613 new confirmed covoravirus cases and 4 deaths. In addition, during this timeframe, there were 90 hospitalizations due to covid-19. These data are for the entire state, and good to see that so far this summer numbers are low for both hospitalization and deaths. Will be important to see if the arrival of the FLiRT variants have an impact on these numbers.Wastewater Ticking up - Boston Globe
Levels of COVID in Mass. waste water tick up with arrival of new ‘FLiRT’ variants
I really wish the next vaccine was targeting KP.2 and not JN strains as they are quickly fading while KP are on the rise.
5/10/24 -
More than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing member of a group of so-called "FLiRT" variants, nicknamed for their small but distinctive changes relative to the JN.1 strain. JN.1 was the variant behind this past winter wave of infections.
The largest among them, called KP.2 by scientists, has quickly multiplied in recent weeks to become the now-dominant new COVID-19 strain.
According to the Centers for Disease Control and Prevention's every-other-week variant estimates, KP.2 and another strain with the same FLiRT mutations, called KP.1.1, together make up a projected 35.3% of infections this week. This is up from 7.1% a month ago.
"FLiRT" COVID variants are now more than a third of U.S. cases. Scientists share what we know about them so far.
Some of the strains in the "FLiRT" group are closely related to the JN.1 COVID variant from last winter.www.cbsnews.com
I totally agree. I thought of that very thing before I even posted. My guess is they are using outdated data. My opinion is from years of working in a large corporation that did that very thing. Red tape, etc., all made it VERY hard to make decisions and change in a timely manner. One of the things they used to say about my company is it was like trying to change the course of a VERY large ship. It's not quick.I wonder what their reasoning was on that decision. As my mother used to say when something didn’t make sense…
“There must be a reason.”
I don't think so.Sorry to be off topic, but has anyone started a thread about H5N1 bird flu? It seems to be a growing concern in the US
In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Wall Street hadwww.statnews.com
I am so sorry to hear this---it is so sad and reaffirms my thoughts that this virus isTucson icon Linda Ronstadt lost her capacity to speak and hear after a second bout of COVID earlier this year.
With the help of therapy and attentive, around-the-clock care, the legendary songstress has regained her speech, she recently told a high school classmate who checked in with her ahead of their 60th reunion at Catalina High School.
Though Ronstadt has regained her speech, she said her hearing loss may be permanent.
Tucson icon Linda Ronstadt regains ability to speak after bout with COVID
Legendary songstress Linda Ronstadt has regained her speech after a bout with COVID earlier this year.tucson.com
All of my shots were Pfizer (round 1, round 2 and subsequent boosters). Each jab of Pfizer knocked me out for a few days. Chills, headache, sore arm from the armpit to the wrist, etc.All my early shots were Moderna, with normal unpleasant side effects for a few days. Then one time I got Pfizer, and I had zero side effects and barely even a sore arm. On the hopeful assumption that all the vaxxes are equal in effectiveness, I now favor Pfizer when given the option.
Novavax wasn't an option in my area early on, but now I think it might be? Is that one supposed to be better? Seems I've heard that.